BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38579576)

  • 1. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
    Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.
    Klairmont MM; Zhou Y; Cheng C; Pui CH; Jeha S; Gruber TA; Liu Y; Inaba H; Choi JK
    Mod Pathol; 2021 Nov; 34(11):2050-2054. PubMed ID: 34148065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
    Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
    Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Incidence of TdT-negative Pre-B Acute Lymphoblastic Leukemia Associated With Poor Prognostic Features Among Mexican Children in Central Mexico.
    Vacek M; Zárraga Vargas LC; González Domínguez E; Garcia Rodriguez L; Tello Teran OA; Mojica Cardoso C; Ocampo Roosens LV; Acevedo Fernandez JJ; Li W; Lee B; Olalla Tapia JS; Flatt T
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e131-e136. PubMed ID: 38132672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.
    Liu L; McGavran L; Lovell MA; Wei Q; Jamieson BA; Williams SA; Dirks NN; Danielson MS; Dubie LM; Liang X
    Am J Clin Pathol; 2004 Jun; 121(6):810-5. PubMed ID: 15198352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
    Yasmeen S; Rajkumar A; Grossman H; Szallasi A
    Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
    Smith RG; Kitchens RL
    Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
    Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
    Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
    Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
    Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
    Jeha S; Choi J; Roberts KG; Pei D; Coustan-Smith E; Inaba H; Rubnitz JE; Ribeiro RC; Gruber TA; Raimondi SC; Karol SE; Qu C; Brady SW; Gu Z; Yang JJ; Cheng C; Downing JR; Evans WE; Relling MV; Campana D; Mullighan CG; Pui CH
    Blood Cancer Discov; 2021 Jul; 2(4):326-337. PubMed ID: 34250504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
    Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
    Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
    Soslow RA; Bhargava V; Warnke RA
    Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
    Xiao H; Wang S; Tang Y; Li S; Jiang Y; Yang Y; Zhang Y; Han Y; Wu X; Zheng L; Li Y; Gao Y
    Int J Cancer; 2023 Jun; 152(11):2383-2395. PubMed ID: 36757202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
    Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
    Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.